HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...
About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...
The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback